Noxopharm Limited (ASX:NOX)
Share Price and News


Company Profile:

Noxopharm Limited is an ASX-listed clinical-stage drug development company focused on the potential treatment of a wide range of cancers. The company operates under the healthcare sector and aims to create unique anti-cancer drugs. It is backed by a solid pipeline of drug candidates including Veyonda®, the first oncology pipeline product. Housed in the non-oncology subsidiary, Nyrada Inc. are four pre-clinical R and D programs.



Code : ASX:NOX Healthcare Company


Noxopharm Limited (ASX:NOX) Latest News